Concepedia

Author

D. J. Hoban

University of Manitoba

Also Known As

Canadian Antimicrobial Resistance Alliance (CARA), D HOBAN, D Hoban, D J Hoban, D. Hoban, D. J. HOBAN, D. J. Hoban, D.J Hoban, D.J. Hoban, D. J. Hoban

133

Publications

3.9K

Citations

36

H-Index

78

Concepts

All Affiliations

University of ManitobaHealth Sciences CentreDiagnostic Services ManitobaSt. Boniface HospitalPublic Health Agency of Canada
DJ

About

D. J. Hoban is an author at University of Manitoba specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

32

1.6K

2

Health Sciences

18

22

1.3K

3

Engineering

1

1

93

4

Nursing

1

1

15

5

Public Health

1

1

15

D. J. Hoban

×

59

Publications

2.9K

Citations

31

H-Index

YearCitations

Worldwide Prevalence of Antimicrobial Resistance in<i>Streptococcus pneumoniae, Haemophilus influenzae,</i>and<i>Moraxella catarrhalis</i>in the SENTRY Antimicrobial Surveillance Program, 1997–1999

D. J. Hoban, G V Doern, A. C. Fluit,

Clinical Infectious Diseases

2001

375

Increasing prevalence and dissemination of NDM-1 metallo- -lactamase in India: data from the SMART study (2009)

Christine Lascols, Meredith Hackel, Steve H. Marshall,

Journal of Antimicrobial Chemotherapy

2011

163

Molecular epidemiology of extended-spectrum  -lactamase-, AmpC  -lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11

Andrew Denisuik, Philippe Lagacé‐Wiens, Johann Pitout,

Journal of Antimicrobial Chemotherapy

2013

153

Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study

George G. Zhanel, Heather J. Adam, Melanie Baxter,

Journal of Antimicrobial Chemotherapy

2013

150

Clinical Significance of a Test for Slime Production in Ventriculoperitoneal Shunt Infections Caused by Coagulase-Negative Staphylococci

Francisco Díaz‐Mitoma, G. K. M. Harding, D. J. Hoban,

The Journal of Infectious Diseases

1987

138

<i>In Vitro</i> Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012

Andrew Walkty, Heather J. Adam, Melanie Baxter,

Antimicrobial Agents and Chemotherapy

2014

113

Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases. Canadian Haemophilus Study Group

S R Scriver, Sharon Walmsley, C L Kau,

Antimicrobial Agents and Chemotherapy

1994

103

In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species

George G. Zhanel, James A. Karlowsky, Gary A. Harding,

Antimicrobial Agents and Chemotherapy

1997

100

Effect of Iron on Conversion of Acetic Acid to Methane During Methanogenic Fermentations

D. J. Hoban, L. van den Berg

Journal of Applied Bacteriology

1979

93

Activity of NXL104 in Combination with β-Lactams against Genetically Characterized Escherichia coli and Klebsiella pneumoniae Isolates Producing Class A Extended-Spectrum β-Lactamases and Class C β-Lactamases

Philippe Lagacé‐Wiens, Franil Tailor, Patricia J. Simner,

Antimicrobial Agents and Chemotherapy

2011

79

Page 1